For the Annual General Meeting of the Company to be held at:Time: 9.00am (Melbourne time, AEDT)Date: Tuesday, 10 November 2026Place: MinterEllison Collins Arch, Level 20 447 Collins Street Melbourne Victoria 3000 Notice of Annual General Meetingand Explanatory MemorandumMesoblast LimitedABN 68 109...
Notice of Annual General Meeting and Proxy Form
Filed with ASX · · 30 pages · English
Summary by 6ix AI
Mesoblast Limited has issued a notice for its upcoming Annual General Meeting, scheduled to take place in Melbourne. The notice outlines various items of business, including the receipt of financial statements, the adoption of the remuneration report, and the election of directors. Shareholders are encouraged to attend in person or view the meeting online, with detailed voting instructions provided. Voting exclusions apply to certain resolutions, particularly those involving remuneration and stock options for directors.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Release
Earlier from Mesoblast
- Appendix 4G and Corporate Governance Statement
- Ceasing to be a substantial holder
- Becoming a substantial holder
- FDA Approves New Potency Assay for Commercial Ryoncil
- Annual Report for Fiscal Year Ending June 30, 2026 (Form 20-F)
Later from Mesoblast
- Annual Report to Shareholders
- Application for quotation of securities - MSB
- Notification regarding unquoted securities - MSB
- Notification of cessation of securities - MSB
- MSB Reports Increased Revenue and Improved Operating Spend
